Contents: Congenital Heart Defect (CHD)
Genetics of CHD
Risk factor-based algorithms for CHD
ACCE criteria
Analytic validity, Clinical validity, Clinical utility and the Ethical, legal and social impact (ELSI)
US-based Framingham algorithm and the UK-based QRISK algorithm
Using SNPs in candidate genes
GWAS identified SNPs
SNPs in combination can improve calibration and risk stratification
The Ethical, Legal and Social considerations of DNA testing
Familial Hypercholesterolaemia
Northwick Park Heart Study II (NPHSII)
Risk score methods.